EL
PTPI

EMFO LLC’s Petros Pharmaceuticals PTPI Stock Holding History

EMFO LLC’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$458 Hold
40
– – ﹤0.01% 275
2024
Q1 		$1.48K Hold
40
– – ﹤0.01% 265
2023
Q4 		$1.41K Hold
40
– – ﹤0.01% 262
2023
Q3 		$1.73K Hold
40
– – ﹤0.01% 275
2023
Q2 		$2.03K Hold
40
– – ﹤0.01% 284
2023
Q1 		$1.4K Hold
40
– – ﹤0.01% 292
2022
Q4 		$2.33K Hold
40
– – ﹤0.01% 276
2022
Q3 		$5K Hold
40
– – ﹤0.01% 289
2022
Q2 		$8K Hold
40
– – 0.01% 282
2022
Q1 		$16K Hold
40
– – 0.01% 259
2021
Q4 		$33K Sell
40
-72
-64% -$42.2K 0.03% 220
2021
Q3 		$56K Hold
112
– – 0.05% 199
2021
Q2 		$88K Buy
+112
New +$89.6K 0.08% 159

Other funds holding PTPI

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EMFO LLC's PTPI Position: Q2 2024 in Review

EMFO LLC held its Petros Pharmaceuticals (PTPI) position steady in Q2 2024 at 40 shares worth $458. The position accounts for ﹤0.01% of the portfolio, ranked #275.

EMFO LLC first reported a position in PTPI in Q2 2021 and has held it in 13 quarters since. The position peaked at $88K in Q2 2021. 11 funds tracked by Wall St. Rank hold PTPI as of Q2 2024.

  • EMFO LLC held 40 shares of Petros Pharmaceuticals worth $458 as of Q2 2024.
  • EMFO LLC left its Petros Pharmaceuticals share count unchanged in Q2 2024.
  • Petros Pharmaceuticals made up ﹤0.01% of EMFO LLC's portfolio in Q2 2024, its #275 holding.
  • EMFO LLC first reported a position in Petros Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's Petros Pharmaceuticals position peaked at $88K in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.